Tang Chun Wai Nelson
@Nan Fung Group Holdings Ltd
Latest period2024 - Q3ReportedManaged Assets$116.07MTotal holdings38
Assets growth rate23.84%Assets growth rate (2-Q avg)5.35%Continuous growth in asset value1 quarters
Portfolio positions
This chart displays the top 10 holdings in Nan Fung Group Holdings Ltd's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 38 positions.
Assets under management
The assets under management (AUM) of Nan Fung Group Holdings Ltd over the past 10 years (40 quarters) show continuous growth in total asset value over the last 1 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 116.07M in assets, with a quarterly growth rate of 23.84% and a 2-quarter average growth rate of 5.35%. The portfolio is managed by Tang Chun Wai Nelson, and others.
Portfolio holdings
Investment | Portfolio % | Reported Value | Recent Activity |
---|---|---|---|
KALVKalvista Pharmaceuticals Inc
| 1.55% | $1.789M 154,522 shares@ $11.59 avg price | Decreased -29.53% |
EXELExelixis Inc
| 1.44% | $1.666M 64,200 shares@ $25.95 avg price | |
ACADAcadia Pharmaceuticals Inc
| 1.37% | $1.584M 102,984 shares@ $15.39 avg price | |
RANIRani Therapeutics Hldgs Inc
| 0.92% | $1.066M 493,584 shares@ $2.16 avg price | |
TRDAEntrada Therapeutics Inc
| 0.68% | $784,330 49,082 shares@ $15.98 avg price | |
BMRNBiomarin Pharmaceutical Inc
| 0.66% | $760,186 10,815 shares@ $70.29 avg price | |
BOLTBolt Biotherapeutics Inc
| 0.66% | $756,185 1.167M shares@ $0.65 avg price | |
BCYCBicycle Therapeutics Plc
| 0.62% | $714,769 31,585 shares@ $22.64 avg price | Increased 82.58% |
BSLKBolt Projs Hldgs Inc
| 0.58% | $665,801 811,952 shares@ $0.83 avg price | New Position |
KYMRKymera Therapeutics Inc
| 0.45% | $514,714 10,875 shares@ $47.34 avg price |